Saturday, November 13, 2010

Is Big Pharma still a good investment?

A recent white paper by Ernest & Young looks at the question.

At one time this industry was posting double digit annual returns but no more. Largese, economies of scale and regulatory scrutiny are some of the issues that have led to declines. 

IS there a chance for return to the good old days? Visionary leadership is the key to returning this sector to its former position. Keep posted.

Review the report for an insightful look into the industry's challenges and changes on the horizon.

Cheers!

No comments:

Post a Comment